Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ABALHOLMEN AS
AS
Active
Org 932079593
Bryggegata 24, 4514 Mandal
Medical specialists activities · NACE 8622
Est. 2023
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 0
EBITDA margin
—
-436% vs 2023
Equity ratio
12.7%
Financial strength
Net profit 2024
NOK -493
-419% vs 2023
EBITDA — year on year
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 0
—
EBITDA
NOK -493
-436%
Net profit
NOK -493
-419%
Total assets
NOK 346K
+639%
Equity
NOK 44K
-1%
Employees
0
—
Company information
Legal name
ABALHOLMEN AS
Org number
932079593
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
15. september 2023
Share capital
NOK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder eller nestleder hver for seg.
Company purpose
Å investere eller forvalte investeringer innen helsetjenester, annen virksomhet og konsulenttjenester innen disse virksomhetene
Contact
Address
Bryggegata 24, 4514 Mandal
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Lindesnes
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
NOK thousands
Item
2023
2024
Revenue
0
0
Staff expenses
−0
−0
EBITDA
−0
−0
Depreciation & amort.
−0
−0
EBIT
−0
−0
Net financials
−0
0
Profit before tax
−0
−0
Tax
−0
−0
Net profit
−0
−0
Balance sheet
NOK thousands
Item
2023
2024
Total assets
47
346
Equity
44
44
Long-term debt
3
303
Short-term debt
0
0
Total debt
3
303
Financial ratios
5-year trend
EBITDA margin
-49300.0%
This company
15.8%
Market median
-312125% vs market
2023
2024
Equity ratio
12.7%
This company
38.2%
Market median
-67% vs market
2023
2024
Return on equity
-1.1%
This company
18.4%
Market median
-106% vs market
2023
2024
Net profit margin
-49300.0%
This company
8.1%
Market median
-608742% vs market
2023
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2023
2024
Debt / equity
6.90×
This company
0.62×
Market median
-1013% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
PR
Paul-Johnny Reckmann
Board of Directors
2025
—
—
PK
Peter Kjellby
Board of Directors
2025
—
—
EM
Erik Myrvang Salvador
Chairman
2023
—
—
HH
Henrik Høyland
Chairman
2025
—
—
GR
Glenn Røksland
Board of Directors
2025
—
—
CL
Cathrin Lytomt Salvador
Deputy Chairman
2023
—
—
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
ABALHOLMEN AS
(this company)
ATTENIA HELSE AS
Board network connections
Board members of ABALHOLMEN AS also hold positions in
0
other companies.
Person
Role here
Other companies
Paul-Johnny Reckmann
Board of Directors
0 companies
Peter Kjellby
Board of Directors
0 companies
Erik Myrvang Salvador
Chairman
0 companies
Henrik Høyland
Chairman
0 companies
Glenn Røksland
Board of Directors
0 companies
Cathrin Lytomt Salvador
Deputy Chairman
0 companies